Answers are grounded in this paper and cite their sources.
Background and Objective: Curcumin (CUR) is the main ingredient of turmeric, has been confirmed to possess anti-inflammatory and anti-oxidative characteristics. Liver diseases are a global health issue as the liver is the essential detoxifying organ. We conducted our study to verify the protective effects of CUR against carbon tetrachloride (CCL 4 ), which stimulates liver and spleen injury in mice. Materials and Methods: Thirty adult male mice were randomly divided into 3 groups (8-10 mice/group). First group served as control group, second one intraperitoneally injected with CCL 4 (0.1 mL kgG 1 , i.p.). The third group intraperitoneally injected with CCL 4 (0.1 mL kgG 1 ) and co-treated with curcumin (200 mg kgG 1 ) intragastrically, the experiment continued for 8 weeks, 3 times/weekly. Results: The CCL 4 increased serum liver enzymes (ALT, AST and ALP), mRNA expression levels of TNF-", IL-1 and IL-6 were detected as pro-inflammatory markers and 5LO, NOX2 and COX-2 as inflammatory biomarkers for liver and spleen, significant elevations was detected in LPO levels. GSH, GST, GPx, CAT and SOD levels as antioxidants were significantly lessened. Histopathological alterations were also detected. Interestingly, curcumin supplementation of CCL 4 treated group decreased expression of inflammatory markers as well as improved antioxidant status and histoarchitecture in liver and spleen. Conclusion: This data suggested that curcumin protect the liver and spleen from acute CCL 4 induced injury in a rodent model by suppressing hepatic and splenic oxidative stress expression levels of inflammatory markers. Therefore, curcumin are potential therapeutic antioxidant agents against acute hepatotoxicity and spleenotoxicity.
No takes yet. Share an insight, caveat, or question.
Abd-Allah et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: